Asher Bio Closes $55 Million Series C Financing to Advance Lead …
Apr 16, 2024 · SOUTH SAN FRANCISCO, Calif., April 16, 2024--Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer, …
OFF
Asher Bio Closes $55 Million Series C Financing To Advance Lead …
3 weeks from now
Apr 16, 2024 · SOUTH SAN FRANCISCO, Calif., April 16, 2024--Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer, …
yahoo.com
OFF
Asher Bio Launches With $55 Million Series A Financing Led By …
3 weeks from now
Mar 23, 2021 · South San Francisco, Calif., March 23, 2021 – Asher Biotherapeutics, a biotechnology company developing precisely targeted immunotherapies for cancer and other …
asherbio.com
OFF
Biotech Asher Secures $55 Million Funding: Phase 1B Trials On The …
3 weeks from now
Apr 17, 2024 · Asher Biotherapeutics, a leader in developing targeted immunotherapies, has secured $55 million in Series C funding led by RA Capital Management. This investment will …
clinicaltrialvanguard.com
OFF
Asher Bio Closes $55M Series C Financing - FinSMEs
3 weeks from now
Apr 17, 2024 · Asher Bio, a San Francisco, CA-based biotechnology company developing precisely-targeted immunotherapies for cancer, autoimmune, and infectious diseases, raised …
finsmes.com
OFF
Asher Bio Closes $55 Million Series C Financing To Advance Lead …
3 weeks from now
Apr 16, 2024 · Asher Bio plans to use the proceeds from this financing to advance the clinical development of its lead program, AB248, a novel CD8+ T cell selective IL-2, generated by …
businesswire.com
OFF
Asher Bio Secures $55M In Series C Funding For Cancer Therapy
3 weeks from now
Apr 18, 2024 · Asher Biotherapeutics raises $55 million in Series C funding led by RA Capital, with AstraZeneca and Bristol Myers Squibb among new investors. ... $55 million raised in …
sliceofhealthcare.com
OFF
Founder Lodge | Asher Biotherapeutics Raises $55,000,000 At Series …
3 weeks from now
Apr 17, 2024 · Asher Biotherapeutics raises $55,000,000 at Series C on 2024-04-17 in Biotechnology Research, industry founded/co-founded by Craig Gibbs ... Asher Bio is a …
founderlodge.com
OFF
Asher Bio Closes $55 Million Series C Financing To Advance Lead …
3 weeks from now
On April 16, 2024 Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer, autoimmune, and infectious diseases, reported the closing of a …
1stoncology.com
OFF
Asher Bio Closes $55 Million Series C Financing To Advance Lead …
3 weeks from now
Apr 17, 2024 · South San Francisco - Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer, autoimmune, and infectious …
marketscreener.com
OFF
Breaking News: Asher Biotherapeutics Secures $55 Million In …
3 weeks from now
Asher Biotherapeutics, a pioneering biotechnology company located in South San Francisco, has successfully secured a funding round, raising an impressive $55 million. Specializing in the …
leadsontrees.com
OFF
Asher Bio Bursts On The Scene With $55M Series A
3 weeks from now
Mar 23, 2021 · SOUTH SAN FRANCISCO, Calif.—Asher Biotherapeutics announced its launch today, following a $55 million Series A financing led by Third Rock Ventures with participation …
drugdiscoverynews.com
OFF
Asher Bio Closes $55 Million Series C Financing To Advance
3 weeks from now
Apr 16, 2024 · SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer, …
biospace.com
OFF
Asher Bio Closes $55M Series A Round For Targeted IL-2 Drugs
3 weeks from now
Mar 23, 2021 · Asher Biotherapeutics Inc. raised $55 million in a series A financing round to take forward a series of engineered cytokines designed to selectively activate T cells or other …
bioworld.com
OFF
Asher Bio Closes $55 Million Series C Financing To Advance Lead …
3 weeks from now
Apr 16, 2024 · SOUTH SAN FRANCISCO, CA, USA I April 16, 2024 I Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer, …
pipelinereview.com
OFF
Asher Bio Raises $55M In Series A Financing - FinSMEs
3 weeks from now
Mar 23, 2021 · Asher Biotherapeutics, a South San Francisco, Calif.-based biotechnology company developing precisely targeted immunotherapies for cancer and other diseases, …
finsmes.com
OFF
Asher Bio Closes $55 Million Series C Financing To Advance Lead …
3 weeks from now
SOUTH SAN FRANCISCO, Calif., April 16, 2024-- Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer, autoimmune, and …
vcaonline.com
OFF
AsherBio Company Profile 2025: Valuation, Funding & Investors
3 weeks from now
Raised to Date Post-Val Status Stage; 6. Later Stage VC (Series C) 16-Apr-2024: $55M: Completed: ... 0.55%: To view AsherBio’s complete cap table history, request access » VC …
pitchbook.com
FAQs about Asher Bio Closes $55 Million Series C Financing to Advance Lead … Coupon?
What happened to Asher Biotherapeutics?
What is Asher Bio's AB248?
What is Asher Bio?
Where is Asher bio located?
What makes Asher bio unique?
Is Asher bio a breakthrough cytokine immunotherapy solution?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
